Alexco Resource Corp. (USA) (NYSEMKT:AXU) with a Zacks Rank #2 (Buy). Alexco Resource Corp. (USA) (NYSEMKT:AXU) shares after opening at $1.35 moved to $1.40 on last trade day and at the end of the day closed at $1.27. Company price to sales ratio in past twelve months was calculated as 1.16 and price to cash ratio as 10.95. Alexco Resource Corp. (USA) (NYSEMKT:AXU) showed a negative weekly performance of -5.93%.
On April 9,2014 China Recycling Energy Corp. (NASDAQ:CREG) a leading industrial waste-to-energy solution provider in China, announced that it expects to benefit from recent policy announcements made by the Chinese government. Mr. Li Keqiang, China’s Premier and Party Secretary of the State Council, chaired an executive meeting of the State Council in February to discuss environmental protection, and in particular air pollution. Environmental protection and energy conservation have become the focus of regional and local governments as they begin to make large investments in environmental protection infrastructure. China Recycling Energy Corp. (NASDAQ:CREG) shares fell -6.67% in last trading session and ended the day on $3.36. CREG return on equity ratio is recorded as 10.60% and its return on assets is 5.70%. China Recycling Energy Corp. (NASDAQ:CREG) yearly performance is 242.86%.
On April 14, 2014 Credit Suisse analyst Bruce Nudell initiated coverage on Mediwound Ltd (NASDAQ:MDWD) with an Outperform rating and $18.00 price target. Mediwound Ltd (NASDAQ:MDWD) shares moved down -6.94% in last trading session and was closed at $10.72, while trading in range of $10.65-$11.65. Mediwound Ltd (NASDAQ:MDWD) year to date performance is -37.93%.
Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) A clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced detailed results from its previously completed Phase IIa trial investigating ORMD-0801. Oramed Pharmaceuticals, Inc. (NASDAQ:ORMP) weekly performance is -0.24%. On last trading day company shares ended up $12.51. Oramed Pharmaceuticals, Inc. (NASDAQ:ORMP) distance from 50-day simple moving average is -4.84%. Analysts mean target price for the company is $31.00.